OLMA
Olema Pharmaceuticals Inc
8.80$
-3.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | +244.4% | +61.3% | +3,046.0% | -74.1% | +0.7% | +2.0% | +1.2% | +0.9% | -0.5% | -78.8% | -2.2% | +0.0% | +6.8% | +1.1% | +91.6% | -29.7% | – | – | – | -36.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -104.9% | – | – | – | -170.3% | – | – | – | – | – | – | |
| – | -12.6% | +144.9% | +140.0% | +34.6% | +70.0% | +11.4% | +5.1% | +27.6% | +0.2% | +69.0% | -34.8% | +22.4% | +5.8% | -21.2% | +8.1% | +33.0% | +15.5% | -2.6% | +14.1% | -2.8% | -5.2% | +43.4% | -9.0% | +8.2% | +13.9% | +17.4% | – | |
| – | +131.8% | +117.3% | +492.8% | +20.3% | +23.8% | -3.1% | +13.6% | +10.4% | +25.3% | -13.9% | -10.3% | +0.7% | +20.2% | -46.7% | +7.7% | +16.8% | -1.9% | -0.8% | -0.6% | +1.7% | -4.9% | -6.8% | +49.6% | +15.8% | +27.5% | +7.3% | – | |
| – | +2.6% | +138.4% | +216.5% | +28.8% | +52.5% | +6.9% | +7.5% | +22.5% | +6.9% | +43.2% | -30.2% | +17.2% | +8.8% | -27.0% | +8.1% | +30.3% | +12.9% | -2.4% | +12.2% | -2.3% | -5.2% | +37.3% | -4.2% | +8.8% | +16.0% | +16.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | -100.0% | – | – | – | – | +90.4% | +49.9% | +101.8% | +4.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +1,000.0% | -97.0% | +2,211,600.0% | -99.5% | -100.9% | – | – | – | – | – | – | – | – | – | – | -170.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.